Cargando…

Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns

PURPOSE: Guidelines recommend testing for EGFR mutation at diagnosis of advanced non–small-cell lung cancer to guide treatment. Two surveys, 18 months apart, aimed to identify changes in EGFR mutation testing and treatment practices in non–small-cell lung cancer. METHODS: The first survey of 562 phy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peters, Matthew, Kim, Edward S., Hirsch, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426511/ https://www.ncbi.nlm.nih.gov/pubmed/30811306 http://dx.doi.org/10.1200/JGO.18.00057

Ejemplares similares

Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases
por: Soo, Ross A., et al.
Publicado: (2021)

A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies
por: Tischer, Bernd, et al.
Publicado: (2017)

Lung nodule management practice patterns – A survey of Indian physicians
por: Mehta, Vishisht, et al.
Publicado: (2020)

Patterns of epidermal growth factor receptor testing across 111 tertiary care centers in India: Result of a questionnaire-based survey
por: Prabhash, Kumar, et al.
Publicado: (2018)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer
por: Jang, Seung Hun, et al.
Publicado: (2022)

International physician survey on management of FOP: a modified Delphi study
por: Di Rocco, Maja, et al.
Publicado: (2017)

Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States
por: Boon, Heather S, et al.
Publicado: (2004)

The future of physician advocacy: a survey of U.S. medical students
por: Chimonas, Susan, et al.
Publicado: (2021)

US Physicians’ Perspective on the Sudden Shift to Telehealth: Survey Study
por: Walia, Bhavneet, et al.
Publicado: (2021)

Physicians’ Perspectives on COVID-19: An International Survey
por: Dima, Alina, et al.
Publicado: (2020)

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists
por: Mileham, Kathryn F., et al.
Publicado: (2021)

The epidermal growth factor receptor (EGRF) in lung cancer
por: Carcereny, Enric, et al.
Publicado: (2015)

The Impact of Health Information on the Internet on Health Care and the Physician-Patient Relationship: National U.S. Survey among 1.050 U.S. Physicians
por: Murray, Elizabeth, et al.
Publicado: (2003)

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study
por: Cuppens, Kristof, et al.
Publicado: (2021)

Physician perspectives on the DNR order in Turkey: A survey of physicians in Internal Medicine
por: Hüseyin, Güvercin Cemal, et al.
Publicado: (2023)

European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review
por: Shah, Riyaz, et al.
Publicado: (2021)

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
por: Baek, Min Young, et al.
Publicado: (2018)

Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists
por: Bartley, Bethany L., et al.
Publicado: (2020)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)
por: Kobayashi, Kunihiko, et al.
Publicado: (2013)

Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
por: Qiao, Xiaojuan, et al.
Publicado: (2015)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer
por: Eriksson, Jennifer, et al.
Publicado: (2019)

Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury
por: Harris, Zachary M., et al.
Publicado: (2022)

150 International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR). Physicians' View
por: Badellino, H. A., et al.
Publicado: (2012)

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
por: Kris, Mark G., et al.
Publicado: (2023)

Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested?
por: Schwitter, Michael, et al.
Publicado: (2013)

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy
por: Filipits, Martin, et al.
Publicado: (2023)

Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians
por: McNamara, Michelle, et al.
Publicado: (2019)

Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
por: Amirabadi, Amir, et al.
Publicado: (2021)

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma
por: Zhang, Lijuan, et al.
Publicado: (2021)

Self-Reported Rationing Behavior Among US Physicians: A National Survey
por: Sheeler, Robert D., et al.
Publicado: (2016)

Cascades of Care After Incidental Findings in a US National Survey of Physicians
por: Ganguli, Ishani, et al.
Publicado: (2019)

Physician Practice Pattern Variations in Common Clinical Scenarios Within 5 US Metropolitan Areas
por: Song, Zirui, et al.
Publicado: (2022)

Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors
por: Fu, Yang, et al.
Publicado: (2020)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
por: Feng, Yongdong, et al.
Publicado: (2021)

Beyond epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing in advanced non-small cell lung cancer: Is the picture as “ROS1” as it appears?
por: Singh, Navneet
Publicado: (2017)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients with Advanced Non-Small Cell Lung Cancer
por: Meriggi, F., et al.
Publicado: (2010)

Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma
por: Kim, Eun-Young, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p2qdaveg5psn3lg7h717l9dfgh